114 related articles for article (PubMed ID: 7571023)
41. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
Lipp RW; Schnedl WJ; Aglas F; Ranner G; Beham-Schmid C; Leb G; Sill H
Acta Med Austriaca; 1999; 26(3):105-8. PubMed ID: 10520379
[TBL] [Abstract][Full Text] [Related]
42. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
DeNardo GL; DeNardo SJ; O'Donnell RT; Kroger LA; Kukis DL; Meares CF; Goldstein DS; Shen S
Clin Lymphoma; 2000 Sep; 1(2):118-26. PubMed ID: 11707820
[TBL] [Abstract][Full Text] [Related]
43. 99mTC-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis.
Gratz S; Raddatz D; Hagenah G; Behr T; Béhé M; Becker W
Int J Cardiol; 2000 Aug; 75(1):75-84. PubMed ID: 11054510
[TBL] [Abstract][Full Text] [Related]
44. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery.
Ivanćević V; Perka C; Hasart O; Sandrock D; Munz DL
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):547-51. PubMed ID: 11914895
[TBL] [Abstract][Full Text] [Related]
45. [Value of scintigraphy with 99mTc-MIBI in the diagnosis and follow-up of Hodgkin's and non-Hodgkin's lymphomas].
Solano Bravo ME; Perera Pintado A; Gómez Pérez JR; Rodríguez Pérez JL; Sánchez Mendoza EL; Pérez Valdés M; Sánchez Del Campo Romero M
Rev Esp Med Nucl; 2000 Apr; 19(2):85-91. PubMed ID: 10799923
[TBL] [Abstract][Full Text] [Related]
46. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
47. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
48. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
[TBL] [Abstract][Full Text] [Related]
49. Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.
Iizuka-Mikami M; Nagai K; Yoshida K; Sugihara T; Suetsugu Y; Mikami M; Tamada T; Imai S; Kajihara Y; Fukunaga M
Eur Radiol; 2004 Jun; 14(6):1074-81. PubMed ID: 14986048
[TBL] [Abstract][Full Text] [Related]
50. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
[TBL] [Abstract][Full Text] [Related]
51. CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
Lundin J; Osterborg A; Brittinger G; Crowther D; Dombret H; Engert A; Epenetos A; Gisselbrecht C; Huhn D; Jaeger U; Thomas J; Marcus R; Nissen N; Poynton C; Rankin E; Stahel R; Uppenkamp M; Willemze R; Mellstedt H
J Clin Oncol; 1998 Oct; 16(10):3257-63. PubMed ID: 9779699
[TBL] [Abstract][Full Text] [Related]
52. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
[TBL] [Abstract][Full Text] [Related]
53. The diagnostic value of 123I-IMP SPECT in non-Hodgkin's lymphoma of the central nervous system.
Akiyama Y; Moritake K; Yamasaki T; Kimura Y; Kaneko A; Yamamoto Y; Miyazaki T; Daisu M
J Nucl Med; 2000 Nov; 41(11):1777-83. PubMed ID: 11079483
[TBL] [Abstract][Full Text] [Related]
54. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
[TBL] [Abstract][Full Text] [Related]
55. Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in (131)I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin's lymphoma.
Boucek JA; Turner JH
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):458-69. PubMed ID: 15821965
[TBL] [Abstract][Full Text] [Related]
56. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
57. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.
DeNardo SJ; DeNardo GL; Kukis DL; Shen S; Kroger LA; DeNardo DA; Goldstein DS; Mirick GR; Salako Q; Mausner LF; Srivastava SC; Meares CF
J Nucl Med; 1999 Feb; 40(2):302-10. PubMed ID: 10025839
[TBL] [Abstract][Full Text] [Related]
58. Radioimmunodetection of residual, recurrent or metastatic germ cell tumors using technetium-99 anti-(alpha-fetoprotein) Fab' fragment.
Amato R; Kim EE; Prow D; Andreopoulos D; Kasi LP
J Cancer Res Clin Oncol; 2000 Mar; 126(3):161-7. PubMed ID: 10741910
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.
Stein R; Qu Z; Chen S; Rosario A; Shi V; Hayes M; Horak ID; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2004 Apr; 10(8):2868-78. PubMed ID: 15102696
[TBL] [Abstract][Full Text] [Related]
60. [In vivo imaging of Hodgkin's lymphomas using monoclonal antibodies].
Pfreundschuh M; Carde P; Da Costa L; Manil L; Lumbroso JD; Caillou B; Boudet F; Ricard M; Hayat M; Diehl V
Onkologie; 1989 Aug; 12 Suppl 1():30-3. PubMed ID: 2555758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]